CVE-2021-33718

Description

A vulnerability has been identified in Mendix Applications using Mendix 7 (All versions < V7.23.22), Mendix Applications using Mendix 8 (All versions < V8.18.7), Mendix Applications using Mendix 9 (All versions < V9.3.0). Write access checks of attributes of an object could be bypassed, if user has a write permissions to the first attribute of this object.

Category

5.3
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.10%
Vendor Advisory siemens.com
Affected: Siemens Mendix Applications using Mendix 7
Affected: Siemens Mendix Applications using Mendix 8
Affected: Siemens Mendix Applications using Mendix 9
Published at:
Updated at:

References

Link Tags
https://cert-portal.siemens.com/productcert/pdf/ssa-352521.pdf vendor advisory

Frequently Asked Questions

What is the severity of CVE-2021-33718?
CVE-2021-33718 has been scored as a medium severity vulnerability.
How to fix CVE-2021-33718?
To fix CVE-2021-33718, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2021-33718 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2021-33718 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2021-33718?
CVE-2021-33718 affects Siemens Mendix Applications using Mendix 7, Siemens Mendix Applications using Mendix 8, Siemens Mendix Applications using Mendix 9.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.